Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

CNTX

Insider Sentiment (TTM):

Last Purchase:2025-06-09Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:74,031,075Shares Outstanding:95,183,718Institutional Ownership Pct.:77.78%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	43	55	66	77	84	89	94	85	102	10	14	22
Prepaid Expense And Other Assets Current	3	4	2	2	3	3	3	1	1	1	2	1
Assets Current	46	59	68	79	87	93	98	86	103	11	16	23
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	-	-	0	0
Assets	46	59	68	79	87	93	98	86	103	11	16	23
Other Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	3	2	3	3	2	1	1	1	1	2	2	2
Accrued Liabilities Current	4	4	5	3	2	1	1	1	1	1	2	3
Operating Lease Liability Current	0	0	0	0	0	0	0	0	-	-	0	0
Liabilities Current	8	7	8	6	5	2	3	2	2	3	4	5
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	-	-	0	-
Liabilities	8	7	8	6	5	2	3	2	2	3	4	5
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	192	192	191	191	191	190	190	175	175	80	80	80
Retained Earnings Accumulated Deficit	-154	-140	-131	-118	-108	-99	-95	-91	-74	-72	-68	-61
Stockholders Equity	38	52	60	73	83	91	95	84	101	8	12	18
Liabilities And Stockholders Equity	46	59	68	79	87	93	98	86	103	11	16	23
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	200	200	200	200	200	200	100	100	100	100	100
Common Stock Shares Issued	92	92	92	92	90	90	90	75	75	16	16	16
Shares Outstanding	92	92	92	92	90	90	90	75	75	16	16	16

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	18.26%	-75.93%	-74.52%	-	-	-	-	-	-	-	-	-
2025	-25.36%	-14.62%	8.80%	20.17%	30.19%	80.26%	-0.88%	0.00%	60.18%	-19.54%	-28.48%	-53.97%
2024	9.39%	10.77%	38.12%	5.13%	-20.51%	0.00%	-31.53%	-50.45%	-59.37%	1.30%	1.43%	-13.77%
2023	-	-	-	6.38%	60.64%	7.45%	-13.09%	4.15%	-10.60%	39.25%	74.77%	59.81%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.81	8.96	8.52	13.10	19.09	48.80	35.62	36.91	64.01	4.23	3.83	4.99
Quick Ratio	5.45	8.34	8.23	12.75	18.33	47.02	34.36	36.36	63.29	3.87	3.45	4.71
Working Capital	37.93M	51.98M	60.33M	73.02M	82.39M	90.83M	95.15M	83.74M	101.09M	8.43M	11.86M	18.37M
Leverage & Debt
Debt to Equity	0.21	0.13	0.13	0.08	0.06	0.02	0.03	0.03	0.02	0.31	0.35	0.25
Interest Coverage TTM	-	-	-	-	-30.80	-15.18	-13.38	-13.23	-13.28	-23.14	-21.54	-17.38
Debt Ratio	0.17	0.11	0.12	0.08	0.05	0.02	0.03	0.03	0.02	0.24	0.26	0.20
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.48	-0.42	-0.38	-0.28	-0.36	-0.29	-0.46	-0.37	-0.34	-1.34	-1.50	-1.30
Free Cash Flow Per Share TTM	-0.29	-0.35	-0.28	-0.18	-0.13	-0.16	-0.25	-0.21	-0.33	-1.23	-1.32	-1.11
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	34.35%	45.57%	35.17%	-12.31%	84.24%	29.60%	11.52%	45.30%	-0.87%	20.43%	61.53%	2.26%
EPS Growth (1Y)	34.35%	45.57%	-17.05%	-25.85%	6.38%	-78.26%	-69.52%	-71.17%	-71.20%	20.43%	61.53%	2.26%
Valuation Metrics
P/E TTM	-1.15	-6.20	-3.87	-3.49	-1.82	-2.11	-2.30	-5.23	-5.93	-1.03	-0.75	-1.16
P/B TTM	1.38	4.78	2.31	1.26	0.76	0.64	0.64	1.88	1.09	2.61	1.52	1.31
Market Cap	52.73M	249.38M	139.92M	92.23M	62.35M	58.25M	61.34M	157.74M	110.19M	22.03M	18.04M	24.11M
Enterprise Value	9.74M	194.85M	73.93M	15.30M	-21.17M	-31.10M	-33.09M	72.94M	8.66M	11.94M	3.59M	2.43M
Calculated Values
Free Cash Flow TTM	-27.66M	-32.89M	-26.49M	-17.39M	-12.75M	-15.27M	-14.56M	-16.88M	-18.40M	-19.68M	-21.05M	-17.75M
Net Debt	-42.99M	-54.53M	-66.00M	-76.94M	-83.52M	-89.35M	-94.43M	-84.80M	-101.54M	-10.09M	-14.45M	-21.68M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-06-09Purchase

Owner: Lehr, Martin A.

Title: Chief Executive Officer

Shares: 100,000

Price/Share: $0.70

Value: $70,000.00

Shares Owned: 920,190

Relationship: Director,Officer

Ownership: Indirect

2025-06-06Purchase

Owner: Minai-Azary, Jennifer Lyn…

Title: Chief Financial Officer

Shares: 40,010

Price/Share: $0.64

Value: $25,606.40

Shares Owned: 80,010

Relationship: Officer

Ownership: Direct

2025-06-06Purchase

Owner: Levit, Alex C.

Title: Chief Legal Officer, Corp. Sec

Shares: 20,000

Price/Share: $0.58

Value: $11,600.00

Shares Owned: 29,000

Relationship: Officer

Ownership: Direct

2023-02-21Purchase

Owner: Lehr, Martin A.

Title: Chief Executive Officer

Shares: 5,823

Price/Share: $0.84

Value: $4,891.32

Shares Owned: 159,701

Relationship: Director,Officer

Ownership: Direct

2023-02-13Purchase

Owner: Lehr, Martin A.

Title: Chief Executive Officer

Shares: 5,606

Price/Share: $0.87

Value: $4,877.22

Shares Owned: 153,878

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-06-09	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Indirect	Purchase	100,000	0.70	$70,000.00	920,190	4
2025-06-06	Minai-Azary, Jennifer Lyn…	Officer	Chief Financial Officer	Direct	Purchase	40,010	0.64	$25,606.40	80,010	4
2025-06-06	Levit, Alex C.	Officer	Chief Legal Officer, Corp. Sec	Direct	Purchase	20,000	0.58	$11,600.00	29,000	4
2023-02-21	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	5,823	0.84	$4,891.32	159,701	4
2023-02-13	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	5,606	0.87	$4,877.22	153,878	4
2023-02-06	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	5,040	0.97	$4,888.80	148,272	4
2023-01-30	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	7,027	0.70	$4,918.90	143,232	4
2023-01-23	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	6,839	0.72	$4,924.08	136,205	4
2023-01-17	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	6,783	0.74	$5,019.42	129,366	4
2022-12-16	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	20,000	0.74	$14,800.00	122,583	4
2022-12-16	Minai-Azary, Jennifer Lyn…	Officer	Chief Financial Officer	Direct	Purchase	25,000	0.74	$18,500.00	40,000	4
2022-12-09	Levit, Alex C.	Officer	Chief Legal Officer, Corp. Sec	Direct	Purchase	6,000	0.85	$5,100.00	9,000	4
2022-08-19	Lehr, Martin A.	Director,Officer	Chief Executive Officer	Direct	Purchase	13,000	1.85	$24,050.00	102,583	4
2022-08-17	Minai-Azary, Jennifer Lyn…	Officer	Chief Financial Officer	Direct	Purchase	15,000	1.80	$27,000.00	15,000	4
2022-08-16	Sahmoud, Tarek	Officer	Chief Medical Officer	Direct	Purchase	10,000	1.95	$19,500.00	10,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

77.78%

Inst. Shares: 74,031,075

Shares Outstanding: 95,183,718

2025-12-31

68.46%

Inst. Shares: 65,168,159

Shares Outstanding: 95,185,683

2025-09-30

72.45%

Inst. Shares: 68,966,266

Shares Outstanding: 95,185,187

2025-06-30

72.09%

Inst. Shares: 68,619,080

Shares Outstanding: 95,186,935

2025-03-31

75.02%

Inst. Shares: 71,407,768

Shares Outstanding: 95,186,935

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	74,031,075	95,183,718	77.78%
2025-12-31	65,168,159	95,185,683	68.46%
2025-09-30	68,966,266	95,185,187	72.45%
2025-06-30	68,619,080	95,186,935	72.09%
2025-03-31	71,407,768	95,186,935	75.02%
2024-12-31	72,731,660	58,416,141	124.51%
2024-09-30	56,682,696	80,481,053	70.43%
2024-06-30	57,009,861	54,958,635	103.73%
2024-03-31	3,895,272	15,966,053	24.40%
2023-12-31	3,526,071	15,966,053	22.08%
2023-09-30	2,548,186	15,966,053	15.96%
2023-06-30	2,210,494	15,966,053	13.84%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Context Therapeutics Inc. (CNTX) — SEC Financial Statements & Analysis

Context Therapeutics Inc. (CNTX) is a pharmaceutical preparations company, incorporated in DE. Context Therapeutics Inc. trades on Nasdaq as: CNTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Context Therapeutics Inc. reported a Debt-to-Equity ratio of 0.21x, a Price-to-Book (P/B) ratio of 1.38x (TTM), at a market cap of $52.73M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.21x
P/B TTM: 1.38x
Market Cap: $52.73M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Context Therapeutics Inc. in?

Context Therapeutics Inc. (CNTX) operates in the Pharmaceutical Preparations industry.

What is CNTX's market cap?

Context Therapeutics Inc. (CNTX) has a market capitalization of $52.73M as of 2026-06-30.

What exchange does CNTX trade on?

Context Therapeutics Inc. (CNTX) trades on the Nasdaq.

Where is Context Therapeutics Inc. incorporated?

Context Therapeutics Inc. is incorporated in DE.